Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
LIM domain and actin binding 1 | 0.711 | 0.231 | 2.7E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
POU class 2 homeobox associating factor 1 | 0.608 | 0.615 | 0.57 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ras homolog family member F, filopodia associated | 0.638 | 0.500 | 1.8E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
POU class 2 homeobox 2 | 0.599 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
SCAN domain containing 2 pseudogene | 1.000 | 0.231 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
leucine zipper transcription factor like 1 | 0.638 | 0.692 | 5.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
MKS transition zone complex subunit 1 | 0.505 | 0.769 | 3.4E-16 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
phosphatidylinositol glycan anchor biosynthesis class X | 0.780 | 0.308 | 2.4E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
solute carrier family 35 member A5 | 1.9E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||||
|
anoctamin 1 | 0.516 | 0.769 | 0.87 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
retroelement silencing factor 1 | 0.931 | 0.115 | 9.3E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
RCC1 and BTB domain containing protein 1 | 0.572 | 0.692 | 1.6E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
leucine rich repeat containing 36 | 7.7E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||||
|
F-box and WD repeat domain containing 7 | 0.465 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
OTU deubiquitinase with linear linkage specificity like | 0.861 | 0.192 | 3.4E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
RAB4B, member RAS oncogene family | 0.890 | 0.192 | 0.67 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 | 0.579 | 0.731 | 1.5E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
tRNA methyltransferase subunit 11-2 | 0.14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||||
|
NCK interacting protein with SH3 domain | 0.612 | 0.577 | 2.2E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
zinc finger C3HC-type containing 1 | 0.760 | 0.308 | 2.6E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
antizyme inhibitor 1 | 0.716 | 0.462 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
Rap guanine nucleotide exchange factor 6 | 0.821 | 0.308 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
WW domain containing oxidoreductase | 0.453 | 0.808 | 1.2E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
synaptotagmin 17 | 1.000 | 0.038 | 1.1E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |